Search by Drug Name or NDC
NDC 50804-0903-19 Motion Sickness 25 mg/1 Details
Motion Sickness 25 mg/1
Motion Sickness is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Geiss, Destin & Dunn Inc.. The primary component is MECLIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Related Packages: 50804-0903-19Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meclizine
Product Information
| NDC | 50804-0903 |
|---|---|
| Product ID | 50804-903_ecddbc8f-f4a3-44ae-a83b-f32f33dbd3d4 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Motion Sickness |
| Proprietary Name Suffix | All Day Less Drowsy |
| Non-Proprietary Name | Meclizine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | MECLIZINE HYDROCHLORIDE |
| Labeler Name | Geiss, Destin & Dunn Inc. |
| Pharmaceutical Class | Antiemetic [EPC], Emesis Suppression [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part336 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 50804-0903-19 (50804090319)
| NDC Package Code | 50804-903-19 |
|---|---|
| Billing NDC | 50804090319 |
| Package | 1 BLISTER PACK in 1 CARTON (50804-903-19) / 8 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2020-04-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |